{
    "code": "02025258",
    "url": "https:\/\/info.fda.gov.tw\/MLMS\/H0001D.aspx?Type=Lic&LicId=02025258",
    "time": "2023-04-07 03:36:21",
    "許可證字號": "衛署藥輸字第025258號",
    "註銷狀態": "",
    "註銷日期": "",
    "註銷理由": "",
    "製造許可登錄編號": "",
    "有效日期": "114\/08\/24",
    "發證日期": "99\/08\/24",
    "許可證種類": "製　劑",
    "舊證字號": "",
    "醫療器材級數": "",
    "第一等級醫療器材原登錄字號": "",
    "第一等級醫療器材新登錄字號": "",
    "通關簽審文件編號": "DHA00202525804",
    "中文品名": "樂伯克持續性藥效錠0.375毫克",
    "英文品名": "Mirapex 0.375mg prolonged-release tablets",
    "適應症": "治療巴金森氏症的徵候及症狀",
    "劑型": "121持續性藥效錠",
    "包裝": "2-1000錠鋁箔盒裝",
    "儲存溫度": "",
    "有效期間": "",
    "指示藥品審查基準": "",
    "標籤、仿單及包裝加註": "",
    "藥品類別": "06須由醫師處方使用",
    "管制藥品分類級別": "",
    "藥品分類": "",
    "監視期限": "",
    "主成分略述": "PRAMIPEXOLE ( PRAMIPEXOLE DIHYDROCHLORIDE MONOHYDRATE)",
    "限制項目": "02輸　入",
    "申請商名稱": "1409106200  台灣百靈佳殷格翰股份有限公司",
    "申請商地址": "台北市中山區民生東路三段2號12樓",
    "主製造廠": [
        {
            "製造廠名稱": "FDE0284100  ROTTENDORF PHARMA GMBH",
            "製造廠廠址": "OSTENFELDER STRASSE 51-61 59320 ENNIGERLOH, GERMANY",
            "製造廠公司地址": "",
            "製造廠國別": "GERMANY",
            "製程": ""
        }
    ],
    "次製造廠": [
        {
            "製造廠名稱": "FDE0021500  BOEHRINGER INGELHEIM INTERNATIONAL GMBH",
            "製造廠廠址": "INGELHEIM AM RHEIN GERMANY",
            "製造廠公司地址": "",
            "製造廠國別": "GERMANY",
            "製程": "許可證持有者"
        },
        {
            "製造廠名稱": "FDE0625000  Rottendorf Pharma GmbH",
            "製造廠廠址": "Am Fleigendahl 3, 59320 Ennigerloh, Germany",
            "製造廠公司地址": "",
            "製造廠國別": "GERMANY",
            "製程": "包裝及分裝"
        }
    ],
    "CCC號列": "30049099904 其他醫藥製劑〈不包括第３００２、３００５或３００６節所列者〉包含經混合或未混合產品供治療或預防疾病用，具有劑量（包括經皮給藥形態者）或零售包裝式樣者Other medicaments (excluding goods of heading 30.02, 30.05 or 30.06) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale",
    "藥理治療分類": "",
    "ingredients": [
        {
            "成分類別": "主成分",
            "成分代碼": "7600001520",
            "成分名稱": "PRAMIPEXOLE ( PRAMIPEXOLE DIHYDROCHLORIDE MONOHYDRATE)",
            "含量描述": "(0.375)",
            "含量": "0.2600000000",
            "單位": "MG"
        }
    ],
    "藥物辨識詳細資料": {
        "外觀尺寸": "",
        "特殊劑型": "",
        "顏色": "白色",
        "特殊氣味": "",
        "刻痕": "有",
        "形狀": "圓凸形",
        "標記一": "P1",
        "標記二": "BI標誌"
    },
    "藥物辨識外觀圖片": [
        {
            "title": "Mirapex 0.375 (3)-104-09-15(廠商自行上傳).pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=02025258&Seq=001&Type=10"
        }
    ],
    "仿單外盒": [
        {
            "title": "樂伯克持續性藥效錠仿單_202111-110-11-03(廠商自行上傳).pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=02025258&Seq=010&Type=9"
        },
        {
            "title": "樂伯克持續性藥效錠仿單-110-10-06(廠商自行上傳).pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=02025258&Seq=009&Type=9"
        },
        {
            "title": "樂伯克持續性藥效錠仿單-110-09-29(廠商自行上傳).pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=02025258&Seq=008&Type=9"
        },
        {
            "title": "樂伯克持續性藥效錠英文仿單-110-09-27(廠商自行上傳).pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=02025258&Seq=007&Type=9"
        },
        {
            "title": "樂伯克持續性藥效錠中文仿單-110-09-27(廠商自行上傳).pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=02025258&Seq=006&Type=9"
        },
        {
            "title": "Mirapex PR all strengths_PIP052191-001-110-03-04(廠商自行上傳).pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=02025258&Seq=005&Type=9"
        },
        {
            "title": "02-樂伯克® 持續性藥效錠(中仿)-109-07-14.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=02025258&Seq=004&Type=9"
        },
        {
            "title": "Mirapex PR 0.375mg blister-110-03-04(廠商自行上傳).pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=02025258&Seq=012&Type=8"
        },
        {
            "title": "PR 0.375mg-FBP052192-001-110-03-04(廠商自行上傳).pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=02025258&Seq=011&Type=8"
        },
        {
            "title": "Mirapex PR 0.375mg blister-110-02-09(廠商自行上傳).pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=02025258&Seq=010&Type=8"
        },
        {
            "title": "MR 0.375 FBP018421-006-108-07-19(廠商自行上傳).pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=02025258&Seq=009&Type=8"
        },
        {
            "title": "FBP018421-003_0.375-104-09-15(廠商自行上傳).pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=02025258&Seq=008&Type=8"
        }
    ]
}